Abbott, Others Marketed Stents Off-Label: Suit

Law360, New York (January 15, 2010, 4:30 PM EST) -- Boston Scientific Corp., Abbott Laboratories and Cordis Corp. engaged in an off-label marketing scheme to promote digestive tract stents for unapproved use in other parts of the body, according to a recently unsealed whistleblower suit by a former medical device executive.

Kevin Colquitt, a former regional sales director for Guidant, which is now part of Boston Scientific, filed the False Claims Act suit in September 2006 in the U.S. District Court for the Northern District of Texas. Judge Barbara Lynn ordered the 100-page complaint unsealed on...
To view the full article, register now.